BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34109612)

  • 21. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Kontopidou FN; Yiakoumis X; Kokoris SI; Dimitriadou EM; Dimopoulou MN; Moschogiannis M; Korkolopoulou P; Kyrtsonis MC; Siakantaris MP; Papadaki T; Tsaftaridis P; Plata E; Papadaki HE; Vassilakopoulos TP
    Oncologist; 2013; 18(2):190-7. PubMed ID: 23345547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
    Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
    Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
    Florindez JA; Alderuccio JP; Reis IM; Lossos IS
    Cancer; 2020 Nov; 126(21):4706-4716. PubMed ID: 32767702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.
    Milosevic R; Todorovic M; Balint B; Jevtic M; Krstic M; Ristanovic E; Antonijevic N; Pavlovic M; Perunicic M; Petrovic M; Mihaljevic B
    World J Gastroenterol; 2009 Aug; 15(32):4009-15. PubMed ID: 19705496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of splenic marginal zone lymphoma.
    Kennedy ND; Lê GN; Kelly ME; Harding T; Fadalla K; Winter DC
    Ir J Med Sci; 2018 May; 187(2):343-347. PubMed ID: 29043543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.
    Fallah J; Olszewski AJ
    Hematology; 2019 Dec; 24(1):378-386. PubMed ID: 30885066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
    de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
    BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress on Treatment of Splenic Marginal Zone Lymphoma-Review].
    Wu L; Tian C; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):600-603. PubMed ID: 28446319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
    Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
    Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
    Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Splenic marginal zone lymphoma].
    Mohamed S
    Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.
    Onisâi M; Vlădăreanu AM; Nica A; Spînu A; Găman M; Bumbea H; Voican I; Iordan I; Alexandru A; Zdrenghea M; Gheorghita D; Grădinaru S
    Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31892196
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of splenectomy in management of splenic B-cell lymphomas.
    Archibald WJ; Baran AM; Williams AM; Salloum RM; Richard Burack W; Evans AG; Syposs CR; Zent CS
    Leuk Res; 2023 May; 128():107053. PubMed ID: 36906942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenic marginal zone lymphoma: a population-based study on the 2001-2008 incidence and survival in the United States.
    Liu L; Wang H; Chen Y; Rustveld L; Liu G; Du XL
    Leuk Lymphoma; 2013 Jul; 54(7):1380-6. PubMed ID: 23101590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
    Muntañola A; Villalobos MT; González-Villambrosia S; Rodríguez-Salazar MJ; Jiménez-Ubieto A; Bastidas-Mora G; Córdoba R; Infante M; Vidal MJ; Díaz FJ; Baile M; Bastos-Oreiro M; Panizo C; Sancho JM; Navarro B; García T; Escoda L; Abrisqueta P; Terol MJ; de Campo R; Mozas P; López-Guillermo A; Salar A; Montalbán C;
    Br J Haematol; 2023 Aug; 202(4):776-784. PubMed ID: 37386877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
    Bennett M; Schechter GP
    Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.